|
|
|
Volumn , Issue 23, 1996, Pages 159-160
|
|
Optimization effects of hydroxypropyl-β-cyclodextrin in combination with nasal absorption enhancer HPE-101
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLODEXTRIN;
CYCLOPENTANONE DERIVATIVE;
FLUORESCEIN DERIVATIVE;
HPE 101;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
INTRANASAL DRUG ADMINISTRATION;
MALE;
MOLECULAR WEIGHT;
NONHUMAN;
NOSE MUCOSA;
RAT;
|
|
EID: 0029815547
PISSN: 10220178
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
